Literature DB >> 31024201

Redefining the Normal Values of Serum Aminotransferases in Healthy Indian Males.

Shaneez Najmy1, Ajay Duseja2, Arnab Pal3, Suchet Sachdev4, Rati R Sharma4, Neelam Marwah4, Yogesh Chawla2.   

Abstract

BACKGROUND: The normal range for Aspartate and Alanine Aminotransferases (AST and ALT) levels (<40 IU/L) were set in 1950s. Recent data from certain countries suggest lower levels of AST and ALT. Aim of the study was to redefine the normal values of aminotransferases in healthy Indian adults.
METHODOLOGY: In a cross sectional prospective study, 1002 blood donors were evaluated to isolate a healthy cohort. Four and 9 subjects positive for HBsAg and anti-Hepatitis C Virus (HCV) respectively and three females were excluded. 986 male subjects were evaluated for levels of serum aminotransferases.
RESULTS: Of total 986 subjects (Group I), 543 (55.1%) had fatty liver on ultrasound [15 (1.5%) alcoholic fatty liver and 528 (53.5%) Nonalcoholic Fatty Liver Disease (NAFLD)]. Median AST and ALT in total group (Group I) were 27.69 (Interquartile Range (IQR) 22.33-37.04) and 34.19 IU/L (IQR 23.12-54.87) and in NAFLD (Group II) were 35.67 (IQR -27.49-47.43) and 50.36 (IQR 37.70-76.58) IU/L. Of remaining 443 subjects without fatty liver, 288 had one or more components of metabolic syndrome. Out of 155 patients with no fatty liver and no component of metabolic syndrome (Group III), 103 subjects had normal Body Mass Index (BMI) and normal cholesterol and Low Density Lipoprotein (LDL) (Group IIIB). Median AST and ALT in Group IIIB were 22.56 (IQR 20.23-26.91) and 21.36 (IQR 17.49-27.21) U/L respectively with a 95th percentile of 34.28 and 36.57 U/L for AST and ALT, respectively.
CONCLUSION: Levels of AST and ALT in healthy men are lower than the conventional values in India.

Entities:  

Keywords:  ALT; LFT, Liver Function Test; NAFLD; TC, Total Cholesterol; TG, Triglyceride; fatty liver; metabolic syndrome; nonalcoholic steatohepatitis; transaminases

Year:  2018        PMID: 31024201      PMCID: PMC6476941          DOI: 10.1016/j.jceh.2018.06.003

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  17 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Alanine aminotransferase levels: what's normal?

Authors:  Marshall M Kaplan
Journal:  Ann Intern Med       Date:  2002-07-02       Impact factor: 25.391

Review 3.  Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies.

Authors: 
Journal:  Lancet       Date:  2004-01-10       Impact factor: 79.321

4.  Re-evaluation of serum alanine aminotransferase upper normal limit and its modulating factors in a large-scale population study.

Authors:  Revital Kariv; Moshe Leshno; Anat Beth-Or; Hana Strul; Laurie Blendis; Ehud Kokia; Dina Noff; Shira Zelber-Sagie; Bracha Sheinberg; Ran Oren; Zamir Halpern
Journal:  Liver Int       Date:  2006-05       Impact factor: 5.828

5.  Upper limit of normal serum alanine and aspartate aminotransferase levels in Korea.

Authors:  Won Sohn; Dae Won Jun; Min Jung Kwak; Quehn Park; Kang Nyeong Lee; Hang Lak Lee; Oh Young Lee; Byung Chul Yoon; Ho Soon Choi
Journal:  J Gastroenterol Hepatol       Date:  2013-03       Impact factor: 4.029

6.  Healthy ranges of serum alanine aminotransferase levels in Iranian blood donors.

Authors:  Mehdi Mohamadnejad; Akram Pourshams; Reza Malekzadeh; Ashraf Mohamadkhani; Afsaneh Rajabiani; Ali Ali Asgari; Seyed Meysam Alimohamadi; Hadi Razjooyan; Mansooreh Mamar-Abadi
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

7.  Updated definitions of healthy ranges for serum alanine aminotransferase levels.

Authors:  Daniele Prati; Emanuela Taioli; Alberto Zanella; Emanuela Della Torre; Sonia Butelli; Emanuela Del Vecchio; Luciana Vianello; Francesco Zanuso; Fulvio Mozzi; Silvano Milani; Dario Conte; Massimo Colombo; Girolamo Sirchia
Journal:  Ann Intern Med       Date:  2002-07-02       Impact factor: 25.391

8.  Prevalence of non-alcoholic fatty liver disease: population based study.

Authors:  Deepak Amarapurkar; Prafull Kamani; Nikhil Patel; Parijat Gupte; Pravin Kumar; Subhash Agal; Rajiv Baijal; Somesh Lala; Dinesh Chaudhary; Anjali Deshpande
Journal:  Ann Hepatol       Date:  2007 Jul-Sep       Impact factor: 2.400

9.  Clinical significance of activity of ALT enzyme in patients with hepatitis C virus.

Authors:  Onder Akkaya; Murat Kiyici; Yusuf Yilmaz; Engin Ulukaya; Omer Yerci
Journal:  World J Gastroenterol       Date:  2007-11-07       Impact factor: 5.742

10.  Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology.

Authors:  Jae Keun Lee; Ju Hyun Shim; Han Chu Lee; Sae Hwan Lee; Kang Mo Kim; Young-Suk Lim; Young-Hwa Chung; Yung Sang Lee; Dong Jin Suh
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

View more
  2 in total

Review 1.  Screening of Cardiovascular Disease in Nonalcoholic Fatty Liver Disease: Whom and How?

Authors:  Narendra S Choudhary; Ajay Duseja
Journal:  J Clin Exp Hepatol       Date:  2019-02-15

2.  Serum Level of Alanine- and Aspartate-Aminotransferase Levels in Newborns in India.

Authors:  Nanda Chhavi; Sachi Ojha; Ashish Awasthi; Amit Goel
Journal:  J Clin Exp Hepatol       Date:  2021-09-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.